Clinical Research Funding Scheme
Clinical Research Funding Scheme supports investigator-led cancer research teams, funding trials, translational studies and sample collection to improve treatment and patient outcomes.
Browse similar grants
Funder: Cancer Research UK
Due Dates: March 27, 2026 (Outline) | June 25, 2026 (Full) | September 7, 2026 (Outline) | December 3, 2026 (Full)
Funding Amounts: No module cost limits; typical Clinical Trial costs £50,000–£200,000/year; typically up to 10 years
Summary: Supports investigator-led cancer trials, translational research, and sample collection to improve treatment and patient outcomes.
Key Information: This is a closed round: contact the clinical research team at least two weeks before submission.
Description
Cancer Research UK’s Clinical Research Funding Scheme supports high-quality, biologically rich clinical and translational research that maximises learning from every participant. Its three interconnected modules—Clinical Trial, Experimental Medicine and Sample Collection—can fund integrated packages or justified standalone studies. Priorities include early-phase proof-of-concept trials, innovative and adaptive designs, treatment optimisation or repurposing, and reducing adverse effects.
Research may investigate treatment response, resistance, toxicity, tumour biology, biomarker validation, or cancer’s effects on whole-body physiology. Strategic priorities include cancers of unmet need, children’s and young people’s cancers, rare cancers, and refinement of radiotherapy and surgery. Teams are expected to include meaningful patient and public involvement, design studies with diversity and inclusion in mind, and reduce barriers to participation for underserved populations.
